Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks

Anne M. Joseph

doi:10.1136/ebm1064

Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks

Anne M. Joseph

Medicine - General Internal Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	87-88
Number of pages	2
Journal	Evidence-Based Medicine
Volume	15
Issue number	3
DOIs	https://doi.org/10.1136/ebm1064
State	Published - Jun 1 2010

Publisher link

10.1136/ebm1064

Find It

Find It at U of M Libraries

Cite this

@article{804051c5dd4a4d4791b7df09eefb2028,

title = "Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks",

author = "Joseph, {Anne M.}",

year = "2010",

month = jun,

day = "1",

doi = "10.1136/ebm1064",

language = "English (US)",

volume = "15",

pages = "87--88",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks

AU - Joseph, Anne M.

PY - 2010/6/1

Y1 - 2010/6/1

UR - http://www.scopus.com/inward/record.url?scp=77953773951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953773951&partnerID=8YFLogxK

U2 - 10.1136/ebm1064

DO - 10.1136/ebm1064

M3 - Comment/debate

C2 - 20522690

AN - SCOPUS:77953773951

SN - 1356-5524

VL - 15

SP - 87

EP - 88

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 3

ER -

Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks

Publisher link

Find It

Other files and links

Cite this